Substance misuse

Changes in alcohol consumption after treatment for depression: a secondary analysis of the Swedish randomised controlled study REGASSA
Catharina Strid, Mats Hallgren, Yvonne Forsell, Martin Kraepelien, Agneta Öjehagen

BMJ Open Nov 2019, 9 (11) e028236; DOI: 10.1136/bmjopen-2018-028236
Risks of psychosis in methamphetamine users: cross-sectional study in Thailand
Warot Lamyai, Kitkawee Pono, Danai Indrakamhaeng, Apichat Saengsin, Nartya Songhong, Panu Khuwuthyakorn, Pongruk Sribanditmongkol, Anongphan Junkuy, Manit Srisurapanont

BMJ Open Oct 2019, 9 (10) e032711; DOI: 10.1136/bmjopen-2019-032711
Ambulatory Smoking Habits Investigation based on Physiology and Context (ASSIST) using wearable sensors and mobile phones: protocol for an observational study
Donghui Zhai, Giuseppina Schiavone, Ilse Van Diest, Elske Vrieze, Walter DeRaedt, Chris Van Hoof

BMJ Open Sep 2019, 9 (9) e028284; DOI: 10.1136/bmjopen-2018-028284
How did the tobacco ban increase inmates’ body weight during incarceration in Canadian federal penitentiaries? A cohort study
Claire Johnson, Jean-Philippe Chaput, Maikol Diasparra, Catherine Richard, Lise Dubois

BMJ Open Jul 2019, 9 (7) e024552; DOI: 10.1136/bmjopen-2018-024552
Psychological correlates and binge drinking behaviours among Canadian youth: a cross-sectional analysis of the mental health pilot data from the COMPASS study
Alexandra Butler, Isabella Romano, Karen Patte, Mark A Ferro, Margaret de Groh, Ying Jiang, Scott T Leatherdale

BMJ Open Jun 2019, 9 (6) e028558; DOI: 10.1136/bmjopen-2018-028558
Prevalence of simultaneous use of alcohol and prescription medication in older adults: findings from a cross-sectional survey (Health Survey for England 2013)
John Foster, Swatee Patel

BMJ Open Jun 2019, 9 (6) e023730; DOI: 10.1136/bmjopen-2018-023730
French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol
Marie Gérardin, Morgane Rousselet, Pascal Caillet, Marie Grall-Bronnec, Pierre Loué, Pascale Jolliet, C Victorri-Vigneau

BMJ Open Jun 2019, 9 (6) e027443; DOI: 10.1136/bmjopen-2018-027443
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment
Annabelle M Belcher, Thomas O Cole, Aaron D Greenblatt, Stephen W Hoag, David H Epstein, Michael Wagner, Amy S Billing, Ebonie Massey, Kristen R Hamilton, Zofia K Kozak, Christopher J Welsh, Eric Weintraub, Emerson M Wickwire, Eric D Wish, Ted J Kaptchuk, Luana Colloca

BMJ Open Jun 2019, 9 (6) e026604; DOI: 10.1136/bmjopen-2018-026604
Assessing the knowledge, attitudes and perceptions of tobacco-associated diseases and how it is influenced by tobacco products advertisement, promotion and sponsorship while enforcing a strong and comprehensive ban in Panama: a cross-sectional study
Hedley Knewjen Quintana, Víctor Herrera, Cecilio Niño, Beatriz Gómez, Reina Roa

BMJ Open Jun 2019, 9 (6) e024373; DOI: 10.1136/bmjopen-2018-024373
User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial
Edward R Melnick, Molly Moore Jeffery, James D Dziura, Jodi A Mao, Erik P Hess, Timothy F Platts-Mills, Yauheni Solad, Hyung Paek, Shara Martel, Mehul D Patel, Laura Bankowski, Charles Lu, Cynthia Brandt, Gail D’Onofrio

BMJ Open May 2019, 9 (5) e028488; DOI: 10.1136/bmjopen-2018-028488

Main menu

Substance misuse

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Substance misuse

Pages